SiMPore Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $225K

  • Investors
  • 7

SiMPore General Information

Description

Developer of nanotechnology designed to offer silicon-based non-porous precision membranes for biomedical and material science applications. The company's products include filters for separating and concentrating biological molecules and nanoparticles, cell culture substrates for growing cells, and electron microscopy grids for preparing and imaging samples at the nanoscale, thereby enabling clients to perform imaging and analysis of nanoscale materials.

Contact Information

Website
www.simpore.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 150 Lucius Gordon Drive
  • Suite 110
  • West Henrietta, NY 14586
  • United States
+1 (888)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 150 Lucius Gordon Drive
  • Suite 110
  • West Henrietta, NY 14586
  • United States
+1 (888)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SiMPore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 20-Jul-2017 $225K Completed
10. Secondary Transaction - Private 01-Mar-2021 Completed Generating Revenue
9. Grant 06-May-2020 Completed Generating Revenue
8. Grant 01-Sep-2019 Completed Generating Revenue
7. Grant 02-Sep-2019 Completed Generating Revenue
6. Grant 01-Jan-2018 Completed Generating Revenue
5. Grant 01-Aug-2017 Completed Generating Revenue
4. Accelerator/Incubator 15-Dec-2010 Completed Generating Revenue
3. Early Stage VC (Series A) 16-Jun-2010 $1M $2.25M Completed Generating Revenue
2. Early Stage VC 30-May-2008 $1.25M $1.25M Completed Generating Revenue
To view SiMPore’s complete valuation and funding history, request access »

SiMPore Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view SiMPore’s complete cap table history, request access »

SiMPore Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nanotechnology designed to offer silicon-based non-porous precision membranes for biomedical and material s
Biotechnology
West Henrietta, NY
19 As of 2023

Cambridge, United Kingdom
 

San Jose, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SiMPore Competitors (2)

One of SiMPore’s 2 competitors is Sphere Fluidics, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom
Molecular Devices Corporate Backed or Acquired San Jose, CA
You’re viewing 2 of 2 competitors. Get the full list »

SiMPore Patents

SiMPore Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11119013-B2 Extracellular vesicle isolation by nanomembranes Active 12-Oct-2018
US-11635357-B2 Extracellular vesicle isolation by nanomembranes Active 12-Oct-2018
US-20200116603-A1 Extracellular vesicle isolation by nanomembranes Active 12-Oct-2018
US-20210372893-A1 Extracellular vesicle isolation by nanomembranes Active 12-Oct-2018
EP-3837544-A1 Devices, methods, and kits for sample analysis using microslit filters Pending 16-Aug-2018 G01N1/4077
To view SiMPore’s complete patent history, request access »

SiMPore Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SiMPore Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of Environmental Health Sciences Government
National Center for Research Resources Government
National Heart, Lung, and Blood Institute Government
National Institute of General Medical Sciences Government
U. S. National Science Foundation Government
You’re viewing 5 of 7 investors. Get the full list »

SiMPore FAQs

  • When was SiMPore founded?

    SiMPore was founded in 2007.

  • Where is SiMPore headquartered?

    SiMPore is headquartered in West Henrietta, NY.

  • What is the size of SiMPore?

    SiMPore has 19 total employees.

  • What industry is SiMPore in?

    SiMPore’s primary industry is Biotechnology.

  • Is SiMPore a private or public company?

    SiMPore is a Private company.

  • What is SiMPore’s current revenue?

    The current revenue for SiMPore is .

  • How much funding has SiMPore raised over time?

    SiMPore has raised $2.25M.

  • Who are SiMPore’s investors?

    National Institute of Environmental Health Sciences, National Center for Research Resources, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, and U. S. National Science Foundation are 5 of 7 investors who have invested in SiMPore.

  • Who are SiMPore’s competitors?

    Sphere Fluidics and Molecular Devices are competitors of SiMPore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »